Logo
  • What we do
    • Phases 1 & 2
    • Phases 3 & 4
    • Post-marketing
    • Consultancy
      • Site qualification
  • Technology
    • Neuroimaging biomarkers
      • Radiological reads
      • Structural MRI
      • PET & SPECT
      • Advanced MRI
    • Assessa platform
      • Assessa PML
    • Digital biomarkers
    • Trial Tracker platform
  • Our expertise
    • Alzheimer's disease (AD)
    • Parkinson's disease (PD)
    • Huntington's disease (HD)
    • Progressive Supranuclear Palsy (PSP)
    • Cerebrovascular disease
    • Multiple Sclerosis (MS)
  • Resources
    • News
    • Blog
    • Webinars
    • Publications
    • Events
  • About us
    • Working at IXICO
      • Information Governance Manager
      • Recruitment privacy notice
      • Quality Assurance Coordinator
    • Collaborations
  • Investors
    • About IXICO
      • Introduction to IXICO
      • Investor FAQs
      • Shareholder info
    • Governance
      • AIM Rule 26
      • Our board
      • Contacts & advisors
      • Oversight
    • Company information
      • Investor videos
      • RNS news
      • Company documents
      • Financial calendar
    • Share price
  • Contact us
  • New elements
  • What we do
  • Technology
  • Our expertise
  • Resources
  • About us
  • Investors
  • Contact us
  • New elements
  • Phases 1 & 2
  • Phases 3 & 4
  • Post-marketing
  • Consultancy
  • Site qualification
  • Neuroimaging biomarkers
  • Assessa platform
  • Digital biomarkers
  • Trial Tracker platform
  • Radiological reads
  • Structural MRI
  • PET & SPECT
  • Advanced MRI
  • Assessa PML
  • Alzheimer's disease (AD)
  • Parkinson's disease (PD)
  • Huntington's disease (HD)
  • Progressive Supranuclear Palsy (PSP)
  • Cerebrovascular disease
  • Multiple Sclerosis (MS)
  • News
  • Blog
  • Webinars
  • Publications
  • Events
  • Working at IXICO
  • Collaborations
  • Information Governance Manager
  • Recruitment privacy notice
  • Quality Assurance Coordinator
  • About IXICO
  • Governance
  • Company information
  • Share price
  • Introduction to IXICO
  • Investor FAQs
  • Shareholder info
  • AIM Rule 26
  • Our board
  • Contacts & advisors
  • Oversight
  • Investor videos
  • RNS news
  • Company documents
  • Financial calendar
  1. Technology
  2. Neuroimaging biomarkers
  3. Radiological reads
  1. Structural MRI

Cookie consent title goes here

Cookie consent content goes here. Lorem ipsum dolor sit amet,sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, At vero eos et accusam et justo duo dolores et ea rebum. Lorem ipsum dolor sit amet, no sea takimata sanctus est Lorem ipsum dolor sit amet. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. no sea takimata sanctus est Lorem ipsum dolor sit amet. no sea takimata sanctus est Lorem ipsum dolor sit amet. sed diam voluptua.

Accept all cookies Manage cookie settings
What we do
Technology
Our expertise
Resources
About us
Investors
Contact us
New elements

IXICO plc
4th Floor, Griffin Court
15 Long Lane
London
EC1A 9PN

VAT number 658 184014
Company number 03131723
registered in England & Wales

IXICO's Quality Management
System is certified to
ISO13485:2016

Terms and conditions |
Privacy Policy |
Blocks |
Sitemap

© 2019 IXICO plc | all rights reserved